Randomised controlled double blind dose-escalation infant trial of the live-attenuated Mycobacterium tuberculosis vaccine MTBVAC

M. Tameris (Cape Town, South Africa)

Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management
Session: Tuberculosis: latest advances and challenges in patient management
Session type: Lunchtime session
Number: 3178
Disease area: Respiratory infections

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Tameris (Cape Town, South Africa). Randomised controlled double blind dose-escalation infant trial of the live-attenuated Mycobacterium tuberculosis vaccine MTBVAC. International Congress 2019 – Tuberculosis: latest advances and challenges in patient management

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effectiveness of influenza vaccination in asthmatic children: randomised, double-blind, placebo-controlled trial
Source: Eur Respir J 2002; 20: Suppl. 38, 146s
Year: 2002

Safety and immunogenicity of a dose-sparing, trivalent inactivated seasonal influenza vaccine containing an advax adjuvant – a phase 1/2 randomised controlled trial
Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention
Year: 2008


Efficacy of recombinant human deoxyribonuclease (Rh-DNase) in infants hospitalised with respiratory syncytial virus bronchiolitis: a multicentre randomised double-blind clinical trial
Source: Eur Respir J 2006; 28: Suppl. 50, 758s
Year: 2006

Atopic disease at 7-years after pertussis vaccination in infancy. Results from a randomized controlled trial of three vaccines
Source: Eur Respir J 2001; 18: Suppl. 33, 452s
Year: 2001

A randomized, controlled, open-label study to evaluate the efficacy and safety of oral lopinavir-ritonavir in adults hospitalized with COVID-19 virus infection
Source: Virtual Congress 2020 – Chinese programme 2020: Part I
Year: 2020


RCT Abstract - Randomized, double-blind, placebo-controlled, phase III clinical trial with MV130, a sublingual bacterial immunotherapy to prevent COPD exacerbations
Source: Virtual Congress 2021 – ALERT: COPD
Year: 2021



Randomized double-blind placebo-controlled trial of azithromycin in lung transplantation: first results
Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation
Year: 2008


Feasibility of shortening intravenous antibiotic therapy for bronchiectasis based on bacterial load: a proof-of-concept randomised controlled trial
Source: Eur Respir J, 58 (6) 2004388; 10.1183/13993003.04388-2020
Year: 2021



A randomized, open-label, parallel design study to compare the immunogenicity of simultaneous administration versus sequential administration of quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in the elderly
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017


Pivot trial A multicentre randomised controlled equivalence trial comparing oral amoxycillin and intravenous penicillin for community acquired pneumonia in children
Source: Eur Respir J 2004; 24: Suppl. 48, 714s
Year: 2004

Randomised double blind placebo controlled trial of selenium supplementation in adult asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 144s
Year: 2006

High-dose inhaled corticosteroids prevent wheeze following respiratory syncytial virus infection: a randomized double-blind placebo-controlled trial
Source: Annual Congress 2008 - Paediatric respiratory epidemiology II: air pollution studies and infectious disease epidemiology
Year: 2008

Experimental hookworm infection as potential therapy for asthma: a randomised placebo controlled trial
Source: Annual Congress 2009 - Epidemiology of atopy and asthma
Year: 2009

Supplementation of N-acetylcysteine as an adjuvant in treatment of newly diagnosed pulmonary tuberculosis patients: A prospective, randomized double blind, placebo controlled study
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013

Results of a phase 2b multi-center, randomized, double-blind, placebo-controlled study of an RNAi therapeutic, ALN-RSV01, in respiratory syncytial virus (RSV)-infected lung transplant patients
Source: Annual Congress 2012 - Novel approaches to lung transplantation
Year: 2012

Randomised, double-blind, placebo-controlled trial of EPS® 7630 in adults with COPD
Source: Annual Congress 2009 - Healthcare and treatment of COPD
Year: 2009


Working memory training efficacy in COPD: the randomised, double-blind, placebo-controlled Cogtrain trial
Source: ERJ Open Res, 7 (4) 00475-2021; 10.1183/23120541.00475-2021
Year: 2021



A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol
Source: Eur Respir J 2016; 48: 320-330
Year: 2016



Randomised controlled trial of azithromycin in smokers with asthma
Source: Eur Respir J 2013; 42: 1412-1415
Year: 2013


Double-blind placebo controlled randomized trial of montelukast in acute RSV bronchiolitis
Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome
Year: 2007